filmov
tv
Presymptomatic treatment for the dementias: plausibility and perils
Показать описание
Nick Fox, Director of the Dementia Research Centre, UCL Institute of Neurology, discusses presymptomatic treatment for the dementias.
This talk was recorded at the British NeuroPsychiatry Association AGM 2014, where Prof Fox was the JNNP Guest Speaker.
References:
Competing interests: NF has received grants from the Medical Research Council, National Institute on Aging (NIH) USA entity, Anonymous Charitable Foundation, Wolfson Foundations, NIHR Biomedical Research Unit, Medical Research Council, Alzheimer's research UK, EPSRC. He has undergone consultancy work for the following, with fees paid directly to University College rather than as personal compensation, Janssen/Pfizer, GE Healthcare, IXICO, Johnson & Johnson, Genzyme (Sonofi company), Eisai, Janssen Alzheimer's Immunotherapy Research and Development, Lilly Research Laboratories (AVID) and Eli Lilly, and Novartis Pharma AG.
This talk was recorded at the British NeuroPsychiatry Association AGM 2014, where Prof Fox was the JNNP Guest Speaker.
References:
Competing interests: NF has received grants from the Medical Research Council, National Institute on Aging (NIH) USA entity, Anonymous Charitable Foundation, Wolfson Foundations, NIHR Biomedical Research Unit, Medical Research Council, Alzheimer's research UK, EPSRC. He has undergone consultancy work for the following, with fees paid directly to University College rather than as personal compensation, Janssen/Pfizer, GE Healthcare, IXICO, Johnson & Johnson, Genzyme (Sonofi company), Eisai, Janssen Alzheimer's Immunotherapy Research and Development, Lilly Research Laboratories (AVID) and Eli Lilly, and Novartis Pharma AG.
0:44:42
0:59:50
0:29:54
0:37:48
0:35:37
0:58:58
0:02:26
0:03:02
0:48:24
0:03:42
0:24:22
0:32:48
0:56:56
1:35:46
0:58:59
0:49:13
0:55:58
0:12:59
1:13:28
0:06:05
0:31:54
0:57:34
0:59:57
0:11:52